BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Diagnosis
215 results:

  • 1. Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A population-based cancer registry study.
    Znaor A; Eser S; Bendahhou K; Shelpai W; Al Lawati N; ELBasmi A; Alemayehu EM; Tazi MA; Yakut C; Piñeros M
    Int J Cancer; 2024 Jul; 155(1):54-60. PubMed ID: 38456478
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Twelve-month progression-free survival with sotorasib and panitumumab in KRAS G12C mutant metastatic colorectal cancer.
    Kavgaci G; Dizdar O; Yalcin S
    Anticancer Drugs; 2024 Jun; 35(5):459-461. PubMed ID: 38451823
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients.
    Ciepiela I; Szczepaniak M; Ciepiela P; Hińcza-Nowak K; Kopczyński J; Macek P; Kubicka K; Chrapek M; Tyka M; Góźdź S; Kowalik A
    Sci Rep; 2024 Feb; 14(1):4619. PubMed ID: 38409377
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Loss of RAS Mutations in Liquid Biopsies of Patients With Multi-Treated Metastatic colorectal cancer.
    Albuquerque J; Neto da Silva D; Padrão T; Leal-Costa L; Bizarro R; Correia J; Baptista C; Machete M; Prazeres G; Margarido I; Fernandes G; Simões P; Timóteo T; Lopes F; Godinho J; Moreira-Pinto J; Rodrigues T; Faria A; Pulido C; Cirnes L; Teixeira JA; Passos Coelho JL
    Oncologist; 2024 Mar; 29(3):e337-e344. PubMed ID: 38071748
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. RIZ2 at the crossroad of the EGF/egfr signaling in colorectal cancer.
    Di Donato M; Di Zazzo E; Salvati A; Sorrentino C; Giurato G; Fiore D; Proto MC; Rienzo M; Casamassimi A; Gazzerro P; Bifulco M; Castoria G; Weisz A; Nassa G; Abbondanza C
    J Transl Med; 2023 Oct; 21(1):736. PubMed ID: 37853459
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Network approach in liquidomics landscape.
    Santini D; Botticelli A; Galvano A; Iuliani M; Incorvaia L; Gristina V; Taffon C; Foderaro S; Paccagnella E; Simonetti S; Fazio F; Scagnoli S; Pomati G; Pantano F; Perrone G; De Falco E; Russo A; Spinelli GP
    J Exp Clin Cancer Res; 2023 Aug; 42(1):193. PubMed ID: 37542343
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma.
    Benusiglio PR; Elder F; Touat M; Perrier A; Sanson M; Colas C; Guerrini-Rousseau L; Tran DT; Trabelsi N; Carpentier C; Marie Y; Adam C; Bernier M; Cazals-Hatem D; Mokhtari K; Tran S; Mathon B; Capelle L; Dhooge M; Idbaih A; Alentorn A; Houillier C; Dehais C; Hoang-Xuan K; Cuzzubbo S; Carpentier A; Duval A; Coulet F; Bielle F
    JCO Precis Oncol; 2023 May; 7():e2200525. PubMed ID: 37262394
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genomic profiling of NGS-based ctDNA from Chinese non-small cell lung cancer patients.
    Xi Y; Bai Z; Gao S; Guo J; Zhang Z; Zhang H; Qu L; Xu B; Wang W; Shan G; Cui W; Bai W; Ji X
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8573-8580. PubMed ID: 37186065
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Analysis of Circulating Tumor DNA in Synchronous Metastatic colorectal cancer at diagnosis Predicts Overall Patient Survival.
    Sayagués JM; Montero JC; Jiménez-Pérez A; Del Carmen S; Rodríguez M; Vidal Tocino R; Montero E; Sanz J; Abad M
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176143
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A review on emerging targeted therapies for the management of metastatic colorectal cancers.
    Deshmukh R; Prajapati M; Harwansh RK
    Med Oncol; 2023 Apr; 40(6):159. PubMed ID: 37097307
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. KRAS Pathways: A Potential Gateway for cancer Therapeutics and Diagnostics.
    Tripathi PK; Mittal KR; Jain N; Sharma N; Jain CK
    Recent Pat Anticancer Drug Discov; 2024; 19(3):268-279. PubMed ID: 37038676
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Targeting HER2 in colorectal cancer].
    Spitzer E; Cervera P; André T; Cohen R
    Bull Cancer; 2023 Apr; 110(4):402-411. PubMed ID: 36870811
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Influence of location-dependent sex difference on PD-L1, MMR/MSI, and egfr in colorectal carcinogenesis.
    Choi J; Kim N; Nam RH; Kim JW; Song CH; Na HY; Kang GH
    PLoS One; 2023; 18(2):e0282017. PubMed ID: 36802389
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer.
    Crucitta S; Ruglioni M; Novi C; Manganiello M; Arici R; Petrini I; Pardini E; Cucchiara F; Marmorino F; Cremolini C; Fogli S; Danesi R; Del Re M
    Clin Chim Acta; 2023 Feb; 541():117239. PubMed ID: 36736684
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Receipt of Targeted Therapy and Survival Outcomes in Patients With Metastatic colorectal cancer.
    Koroukian SM; Booker BD; Vu L; Schumacher FR; Rose J; Cooper GS; Selfridge JE; Markt SC
    JAMA Netw Open; 2023 Jan; 6(1):e2250030. PubMed ID: 36656585
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. CircIFNGR2 enhances proliferation and migration of CRC and induces cetuximab resistance by indirectly targeting KRAS via sponging to MiR-30b.
    Zhang Q; Zheng Y; Liu J; Tang X; Wang Y; Li X; Li H; Zhou X; Tang S; Tang Y; Wang X; He H; Li T
    Cell Death Dis; 2023 Jan; 14(1):24. PubMed ID: 36639711
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Retrospective Analysis of Treatment Pathways in Patients With BRAF
    Gerger A; Eisterer W; Fuxius S; Bastian S; Koeberle D; Welslau M; Sanoyan DA; Maas C; Uhlig J; Fenchel K; Greil R; VON DER Heyde E; Agocs GR; Weide R; Schwager M; Reichenbach F; Modest DP; Fritsch R
    Anticancer Res; 2022 Oct; 42(10):4773-4785. PubMed ID: 36191968
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis.
    He SY; Li YC; Wang Y; Peng HL; Zhou CL; Zhang CM; Chen SL; Yin JF; Lin M
    World J Gastroenterol; 2022 Jul; 28(25):2920-2936. PubMed ID: 35978873
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.
    Zuo Y; Zhong J; Bai H; Xu B; Wang Z; Li W; Chen Y; Jin S; Wang S; Wang X; Wan R; Xu J; Fei K; Han J; Yang Z; Bao H; Shao Y; Ying J; Song Q; Duan J; Wang J
    EBioMedicine; 2022 Aug; 82():104165. PubMed ID: 35901658
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Expression profiling of cancer-related long non-coding RNAs revealed upregulation and biomarker potential of HAR1B and JPX in colorectal cancer.
    Khajehdehi M; Khalaj-Kondori M; Hosseinpour Feizi MA
    Mol Biol Rep; 2022 Jul; 49(7):6075-6084. PubMed ID: 35526243
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.